EA
MNTA

Emerald Acquisition’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Emerald Acquisition’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$369K Buy
31,559
+10,803
+52% +$127K ﹤0.01% 2544
2016
Q2 		$224K Buy
+20,756
New +$214K ﹤0.01% 2704

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Emerald Acquisition's MNTA Position: Q3 2016 in Review

Emerald Acquisition increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 52% in Q3 2016, buying an estimated $127K and bringing the position to 31,559 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Emerald Acquisition first reported a position in MNTA in Q2 2016 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold MNTA as of Q3 2016.

  • Emerald Acquisition held 31,559 shares of Momenta Pharmaceuticals, Inc. worth $369K as of Q3 2016.
  • Emerald Acquisition bought 10,803 Momenta Pharmaceuticals, Inc. shares in Q3 2016, an estimated $127K.
  • Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2544 holding.
  • Emerald Acquisition first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.